Neladalkib Proves Effective in TKI-Pretreated, Advanced ALK+ NSCLC @danafarber.bsky.social #lcsm #oncology www.onclive.com/view/neladal...

Zanidatamab Plus Chemo ± Tislelizumab Impresses in HER2+ Gastroesophageal Adenocarcinoma #GIcancer #oncology www.onclive.com/view/zanidat...

@roswellpark.bsky.social Achieves National Accreditation for #RectalCancer Care #oncology www.onclive.com/view/roswell...

PanTRKare Approved in China as Companion Diagnostic for Entrectinib in #NTRK+ Solid Tumors #oncology www.onclive.com/view/pantrka...

FDA Grants Fast Track Designation to 4A10 for Relapsed/Refractory Acute Lymphoblastic Leukemia @bcmhouston.bsky.social @fda.gov #leusm #hematology www.onclive.com/view/fda-gra...

New #OncLive Podcast Series Launches With Focus on Gynecologic Oncology #oncology www.onclive.com/view/new-onc...

Advances With Checkpoint Inhibitors, T-Cell Engagers, and ADCs Converge to Reshape the SCLC Treatment Paradigm @charlesrudin.bsky.social @mskcancercenter.bsky.social #NYLung25 #lcsm #oncology www.onclive.com/view/advance...

Beyond the Genome: Exploring New Frontiers in NSCLC Management @mskcancercenter.bsky.social #gotoPER #lcsm #oncology www.onclive.com/view/beyond-...

Immunotherapy Advances in SCLC Highlight Promise, Limitations, and Biomarker Needs #oncology #lcsm #lungcancer #SCLC www.onclive.com/view/immunot...

AMT-253 Demonstrates Early Efficacy and Manageable Safety in Melanoma @myesmo.bsky.social #ESMO25 #oncology #melsm www.onclive.com/view/amt-253...

Phase 3 Data Illuminate Advancing Roles for T-DXd and Combination Approaches in HER2+ #BreastCancer #oncology #cancercare www.onclive.com/view/phase-3...

Post-Operative Lymphatic ctDNA Data Shows Superior Sensitivity for Detecting Residual Disease in HPV-Independent HNSCC @upmc.com #hncsm #oncology www.onclive.com/view/post-op...

Adjuvant Satri-Cel Displays Preliminary Activity in Pancreatic Ductal Adenocarcinoma #pancreaticcancer #oncology #CART www.onclive.com/view/adjuvan...

Researchers Develop New AI Tool That Makes Detection of Skin Cancer More Accurate @foxchasecancer.bsky.social #oncology #AI #skincancer www.onclive.com/view/researc...

This episode of OncLive On Air was filmed LIVE at #CFS25! Hear @benlevylungdoc.bsky.social & Dr Tagawa highlight developments in GU cancer management. Watch the video on our site, or listen wherever you get your podcasts! @weillcornell.bsky.social #kcsm #pcsm www.onclive.com/view/psma-th...

BREAKING: @fda.gov Approves New Pertuzumab Biosimilar for Select HER2+ Breast Cancer Subtypes Read more: www.onclive.com/view/fda-app... #FDAapproved #bcsm #oncology

🎤 Panelists discuss how transplant eligibility should be viewed as a continuum based on frailty rather than a binary decision for patients with #multiplemyeloma. #oncology #cancercare Watch the full video here! ⬇️ www.onclive.com/view/transpl...

FDA Grants 510(k) Clearance to EXENT System for Multiple Myeloma Diagnosis #oncology #myeloma www.onclive.com/view/fda-gra...

Efforts to Leverage NaPi2b Are Renewed With Novel ADC in Ovarian Cancer #oncology #ovariancancer www.onclive.com/view/efforts...

[email protected] Accepts NDA For 177Lu-edotreotide for GEP-NETs #oncology www.onclive.com/view/fda-acc...

BREAKING 🚨: @fda.gov Approves Ziftomenib for NPM1+ R/R Acute Myeloid Leukemia Learn more about the approval here 📰: onclive.com/view/fda-app... #leusm #oncology #FDAapproved

Emerging ADC Data and Combination Strategies Are Set to Redefine First-Line TNBC Management @texasoncology.bsky.social #bcsm #oncology www.onclive.com/view/emergin...

Anito-Cel Emerges as Potential Novel Option in R/R Multiple Myeloma @uscsomg.bsky.social #mmsm #hematology www.onclive.com/view/anito-c...

Tinostamustine Snags FDA Orphan Drug Designation for Malignant Glioma @fda.gov #btsm #oncology www.onclive.com/view/tinosta...

FDA Grants Fast Track Designation to AVZO-1418/DB-1418 for EGFR+, TKI-Pretreated #NSCLC www.onclive.com/view/fda-gra...

Oncology Experts and AI Advocates Explain the Evolving Role of AI in Insurance Appeals #oncology #AI www.onclive.com/view/oncolog...

Immunotherapy Resistance in Kidney Cancer Driven by Myeloid Cell Signaling @vanallenlab.bsky.social @danafarber.bsky.social #kcsm #oncology www.onclive.com/view/immunot...

NALIRIFOX Expands Frontline Options in Metastatic Pancreatic Cancer #oncology #pancreaticcancer www.onclive.com/view/nalirif...

CONGRATS Trial Data of Nivolumab ± Relatlimab Highlight Clinical Value of Immunotherapy in TLS+ Soft Tissue #Sarcoma #Oncology 🧬 www.onclive.com/view/congrat...

MD Anderson Experts Spotlight Key Immunotherapy Advances at 2025 SITC Annual Meeting @mdanderson.bsky.social @sitcancer.bsky.social #SITC25 #oncology www.onclive.com/view/md-ande...

Detalimogene Produces 63% CR Rate in BCG-Unresponsive #NMIBC with CIS #oncology www.onclive.com/view/detalim...

Precision Survivorship Platforms Are Essential for Improved, Equitable Care in Pediatric and AYA #Sarcoma #oncology www.onclive.com/view/precisi...

At 3 Years, Eque-Cel Displays Deep and Durable Responses in Relapsed Multiple Myeloma #IMS25 #mmsm #hematology www.onclive.com/view/at-3-ye...

Early Activity With DB-1305/BNT325 Signals Potential Expansion of TROP-2 ADCs in Pretreated Metastatic TNBC @erikahamilton9.bsky.social #oncology #bcsm www.onclive.com/view/early-a...

Lutetium Lu 177 Vipivotide Tetraxetan Enables Some Patients with mCRPC to Avoid Chemotherapy #colorectalcancer #oncology www.onclive.com/view/lutetiu...

Pharmacists Play Key Role in Patient Education and Treatment Adherence in CML Management #leusm #oncology www.onclive.com/view/pharmac...

@ucsfcancer.bsky.social Urology Clinicians Present Research Findings at #SurgeWest25 #oncology #prostatecancer www.onclive.com/view/ucsf-ur...

Chan Breaks Down the Need for Dose Escalation With Somatostatin Analogs in GEP-NETs @danafarber.bsky.social @harvardmed.bsky.social @nanets.bsky.social #NANETS25 #medtwitter #oncology www.onclive.com/view/chan-br...

Yale Study Sheds Light on Cellular Resistance to Osimertinib in Adenocarcinoma @yalecancer.bsky.social #oncology www.onclive.com/view/yale-st...

Camizestrant Plus CDK4/6 Inhibition Causes Minimal Effect on Visual QOL in HR+, ESR1-Mutated Breast Cancer #oncology #bcsm www.onclive.com/view/camizes...

Sign up to read insights from @surbhisidanamd.bsky.social & Joshua Richter, MD, about how the @fda.gov approval of BVd is set to reframe R/R myeloma management! @stanfordhealthcare.bsky.social @mountsinainyc.bsky.social #mmsm #hematology www.onclive.com/view/bvd-app...

BREAKING 🚨: @fda.gov Approves Subcutaneous Daratumumab for High-Risk Smoldering Multiple Myeloma Read all about it 📰: onclive.com/view/fda-app... #mmsm #FDAapproved #oncology

Adjuvant Durvalumab Plus Tremelimumab Yields DFS Advantage in Resected RCC @myesmo.bsky.social #ESMO2025 #ESMO25 #kcsm #oncology www.onclive.com/view/adjuvan...

UGN-103 Yields High 3-Month CR Rate in Low-Grade, Intermediate-Risk NMIBC #oncology #NMIBC #urothelialcancer www.onclive.com/view/ugn-103...

JAK Inhibitor Selection and Sequencing Strategies Are Key in #Myelofibrosis Management @akritigjain.bsky.social #oncology www.onclive.com/view/jak-inh...

Sneaky Senescent Cells That Resist Cancer Treatment Can Provide Druggable #LungCancer Target @ucsfcancer.bsky.social #oncology www.onclive.com/view/sneaky-...

FDA Grants Orphan Drug Designation to M2T-CD33 for Acute Myeloid #Leukemia #leusm #oncology www.onclive.com/view/fda-gra...

HER2DX Could Aid Chemotherapy Decision-Making in Older HER2+ Early-Stage #BreastCancer www.onclive.com/view/her2dx-...

GEP-NET–Focused Research Refines Optimal PRRT Use in Well-Differentiated Disease #oncology #pancreaticcancer @mskcancercenter.bsky.social www.onclive.com/view/gep-net...

Immune-Modulatory and mRNA-Based #CancerVaccines Could Boost Benefit With ICIs Across #SolidTumors Watch the full video and read the article here! www.onclive.com/view/immune-...